Literature DB >> 24906850

Research into a functional cure for HIV in neonates: the need for ethical foresight.

Seema K Shah1, Deborah Persaud2, David S Wendler3, Holly A Taylor4, Hannah Gay5, Mariana Kruger6, Christine Grady3.   

Abstract

In 2013, researchers announced that a newborn child from Mississippi, USA might have been functionally cured of HIV by being given combination antiretroviral therapy within hours of birth. Public and media attention has since been captured by the possibility of finding a cure for HIV transmitted from mother to child. Research into the strategy used for the Mississippi patient is crucially important to establish whether it can be replicated and shown to work in diverse populations. At the same time, any ethical issues likely to arise in such studies should be addressed and not ignored in the pursuit of a functional cure. In this Personal View we identify ethical issues that could arise in research towards achievment of a functional cure for HIV in neonates, including difficult trade-offs associated with choosing the study population and questions about the broader social implications of the research, and propose ways to resolve them.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24906850      PMCID: PMC4219548          DOI: 10.1016/S1473-3099(14)70766-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  33 in total

1.  Investigators' responsibilities for human subjects in developing countries.

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

2.  The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer.

Authors:  M M Mello; T A Brennan
Journal:  Health Aff (Millwood)       Date:  2001 Sep-Oct       Impact factor: 6.301

3.  Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.

Authors:  Kathleen M Powis; Laura Smeaton; Anthony Ogwu; Shahin Lockman; Scott Dryden-Peterson; Erik van Widenfelt; Jean Leidner; Joseph Makhema; Max Essex; Roger L Shapiro
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

4.  Absence of detectable HIV-1 viremia after treatment cessation in an infant.

Authors:  Deborah Persaud; Hannah Gay; Carrie Ziemniak; Ya Hui Chen; Michael Piatak; Tae-Wook Chun; Matthew Strain; Douglas Richman; Katherine Luzuriaga
Journal:  N Engl J Med       Date:  2013-10-23       Impact factor: 91.245

5.  Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.

Authors:  Cornelia Feiterna-Sperling; Katharina Weizsaecker; Christoph Bührer; Simone Casteleyn; Andrea Loui; Thomas Schmitz; Volker Wahn; Michael Obladen
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

6.  Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.

Authors:  Hélène C F Côté; Janet Raboud; Ari Bitnun; Ariane Alimenti; Deborah M Money; Evelyn Maan; Adriana Costei; Izabelle Gadawski; Christina Diong; Stanley Read; Sandy Shen; P Richard Harrigan; David R Burdge; Susan M King; John C Forbes
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

7.  Vulnerability in research and health care; describing the elephant in the room?

Authors:  Samia A Hurst
Journal:  Bioethics       Date:  2008-05       Impact factor: 1.898

8.  Barriers to prevention of mother-to-child transmission of HIV services in Uganda.

Authors:  A K Mbonye; K S Hansen; F Wamono; P Magnussen
Journal:  J Biosoc Sci       Date:  2009-11-09

9.  HIV cure research: expanding the ethical considerations.

Authors:  Jeremy Sugarman
Journal:  Ann Intern Med       Date:  2013-10-01       Impact factor: 25.391

10.  A randomized controlled trial of short and standard-length consent forms for a genetic cohort study: is longer better?

Authors:  Kenji Matsui; Reidar K Lie; Tanvir C Turin; Yoshikuni Kita
Journal:  J Epidemiol       Date:  2012-03-24       Impact factor: 3.211

View more
  12 in total

1.  Ethics of HIV research in children.

Authors:  Theresa M Rossouw; Johanna Crane; Lisa M Frenkel
Journal:  Lancet Infect Dis       Date:  2015-05-17       Impact factor: 25.071

Review 2.  Very early combination antiretroviral therapy in infants: prospects for cure.

Authors:  Kaitlin Rainwater-Lovett; Katherine Luzuriaga; Deborah Persaud
Journal:  Curr Opin HIV AIDS       Date:  2015-01       Impact factor: 4.283

3.  The ethics of HIV "cure" research: what can we learn from consent forms?

Authors:  Gail E Henderson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

4.  Inequality and ethics in paediatric HIV remission research: From Mississippi to South Africa and back.

Authors:  Johanna T Crane; Theresa M Rossouw
Journal:  Glob Public Health       Date:  2016-07-25

5.  HIV cure research in South Africa: a preliminary exploration of stakeholder perspectives.

Authors:  Keymanthri Moodley; Ciara Staunton; Malcolm de Roubaix; Mark Cotton
Journal:  AIDS Care       Date:  2015-11-13

6.  What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent.

Authors:  Holly L Peay; Gail E Henderson
Journal:  J Virus Erad       Date:  2015-01-01

7.  Research gaps in neonatal HIV-related care.

Authors:  Mary-Ann Davies
Journal:  South Afr J HIV Med       Date:  2015-05-20       Impact factor: 2.744

Review 8.  Ethics of HIV cure research: an unfinished agenda.

Authors:  Karine Dubé; John Kanazawa; Jeff Taylor; Lynda Dee; Nora Jones; Christopher Roebuck; Laurie Sylla; Michael Louella; Jan Kosmyna; David Kelly; Orbit Clanton; David Palm; Danielle M Campbell; Morénike Giwa Onaiwu; Hursch Patel; Samuel Ndukwe; Laney Henley; Mallory O Johnson; Parya Saberi; Brandon Brown; John A Sauceda; Jeremy Sugarman
Journal:  BMC Med Ethics       Date:  2021-06-30       Impact factor: 2.834

9.  How to keep high-risk studies ethical: classifying candidate solutions.

Authors:  Nir Eyal
Journal:  J Med Ethics       Date:  2016-06-09       Impact factor: 2.903

10.  When to start paediatric testing of the adult HIV cure research agenda?

Authors:  Seema K Shah
Journal:  J Med Ethics       Date:  2016-06-03       Impact factor: 5.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.